Metabolic secondary outcomes included HbA1c, blood pressure (systolic and diastolic), HR, total cholesterol, triglycerides, hsCRP, HbA1c in participants with pre-existing pre-diabetes and T2D, blood pressure in participants with pre-existing hypertension and changes in T2D, and hypertension medication used in participants with T2D and hypertension, respectively
It is important to document baseline weight at the time the medication is started , as insurers often compare renewal weight to the original starting weight
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish with gradual dose titration
T.SabapathyS.KuckL.SimmondsM
How Pre-Injection Prep Prevents Complications at MedRein Our approach to injectable safety begins weeks before you sit in our chair
Non-uniformity of projection distributions attenuates resolution in Cryo-EM